Diabetes increases the risk of serious adverse events after re-irradiation of the spine.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
07 2019
Historique:
received: 28 11 2018
revised: 26 03 2019
accepted: 02 04 2019
pubmed: 25 4 2019
medline: 1 4 2020
entrez: 25 4 2019
Statut: ppublish

Résumé

In this study we investigate the risk of radiation-induced serious adverse event of the spine in a large cohort of consecutive retreated patients with palliative radiotherapy (RT) for metastatic cancer in the spine. From 2010 to 2014, 2387 patients received spinal irradiation with a palliative intent for metastatic spinal cord compression at our institution. The patients were reviewed for prior RT and 220 patients had received re-irradiation of the spine. Clinical and treatment data were obtained from the patients' records and the RT planning system. Patients had metastatic disease from breast, prostate, lung, hematological or other cancers (22.7%, 21.8%, 21.4%, 3.2% and 30.9%, respectively). Median follow-up was 99 days. Median cumulative EQD2 was 57.6 Gy The incidence of RIM and RIF (6 and 9 out of 220 patients, respectively) was low in our cohort of re-irradiated patients. Patients with diabetes had a higher risk of adverse events which should be considered before re-irradiation of the spine.

Identifiants

pubmed: 31015114
pii: S0167-8140(19)30161-6
doi: 10.1016/j.radonc.2019.04.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-135

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Morten Hiul Suppli (MH)

Department of Oncology, Section of Radiotherapy, Copenhagen, Denmark. Electronic address: morten.hiul.suppli@regionh.dk.

Per Munck Af Rosenschöld (P)

Department of Oncology, Section of Radiotherapy, Copenhagen, Denmark. Electronic address: Per.munckafrosenschold@skane.se.

Helle Pappot (H)

Department of Oncology, Section of Radiotherapy, Copenhagen, Denmark. Electronic address: Helle.pappot@regionh.dk.

Svend Aage Engelholm (SA)

Department of Oncology, Section of Radiotherapy, Copenhagen, Denmark. Electronic address: Svend.aage.engelholm@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH